XOMA Royalty Corp (XOMA)
XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
Address
2200 POWELL STREET
EMERYVILLE, CA 94608
Founded
1981
Number of Employees
13
Website
http://www.xoma.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | - | - | - | $13 | $13 |
Average Price | - | - | - | - | - | - | - | - | - | - | $19.88 | $19.88 |
# Shares Purchased | - | - | - | - | - | - | - | - | - | - | 660 | 660 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | - | - | - | 40.8% | 40.8% |
S&P 500 Return to Date | - | - | - | - | - | - | - | - | - | - | 7.4% | 7.4% |
Excess Total Return | - | - | - | - | - | - | - | - | - | - | 33.4% | 33.4% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | - | - | - | 94% | 67% |
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)